Private Equity

Kathleen Fisher Enyeart, counsel at Lathrop GPM, recently spoke with JDSupra to highlight key healthcare regulatory trends that she expects will shape the landscape for ASCs and physicians in the coming year.

Charlotte, N.C.-based independent practice Tryon Medical Partners finalized a deal with private equity firm TPG in September, six years after breaking away from Atrium Health, North Carolina Health News reported Oct. 9.

Despite recent declines in activity, private equity interest in the ASC space has been high over the last several years, with 95 outpatient-specific deals in 2023 alone. 

Here are five transactions, legislative updates and other private equity updates in the ASC space from third quarter of 2024, as reported by Becker's:

In the last decade, private equity investment has become a key strategy for achieving economies of scale, particularly for independent, physician-owned ASCs in more consolidated markets. 

Medicare expenditures in private equity-affiliated private practices were an average of 9.8% lower than for patients treated in hospital-affiliated practices in 2022, according to a recent study by Avalere and the American Independent Medical Practice Association. 

The California legislature recently passed a bill requiring private equity groups and hedge funds to give written notice, and in certain cases obtain consent, before investing in the state's healthcare industry.  

Private equity has long shown interest in ASCs, but some industry leaders believe that heightened scrutiny of PE’s healthcare investments could dampen this trend.

Becker's connected with Nilesh Dave, MD, vice president of clinical effectiveness and chief medical officer at Arlington-based Texas Health Resources to discuss the role of profit-driven companies in healthcare.

Private equity firms have solidified their place in healthcare over the last decade. 2012 saw just 75 PE transactions in healthcare –– in 2021, that number reached 484.